Article

Ophthonix upgrades to larger facility

Ophthonix Inc. has moved its headquarters effective Sept. 17 to accommodate growth in business and operations.

Vista, CA-Ophthonix Inc. has moved its headquarters effective Sept. 17 to accommodate growth in business and operations.

The company relocated from Sorrento Valley, CA, to a 45,000-sq. ft. facility in Vista. The new facility is more than double the previous space at Pacific Center Court, and will house both corporate offices and a much larger manufacturing operation.

Stephen Osbaldeston, chief executive officer of Ophthonix, said, "The new facility will provide optimum space for an advanced, fully automated optical lab and will enable us to meet increasing customer demand for many years to come."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
© 2025 MJH Life Sciences

All rights reserved.